New biopsy technique may boost sarcoidosis diagnosis rates
NCT ID NCT05374447
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a tiny forceps biopsy to the standard needle biopsy during a lung ultrasound procedure helps doctors diagnose sarcoidosis more often. Fifty-five adults with enlarged lymph nodes in the chest took part. The goal was to see if the combined approach gives a clearer diagnosis than the needle alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDIASTINAL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The George Washington University Hospital
Washington D.C., District of Columbia, 20037, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI could help doctors diagnose lung cancer faster during a bronchoscopy
- Could a monthly shot beat daily pills for lung sarcoidosis?
- Lung doctors take on lab role: can they match pathologists?
- Weight loss drug ozempic tested in lung disease patients
- Does shaking the needle more during a lung biopsy improve results?
- Could antibiotics tame sarcoidosis? new study investigates